Perbedaan Diagnos Laboratorium Utama Tbk. dan Sarana Menara Nusantara Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp232 (kapitalisasi pasar 316,25 M, volume 24 jam 41,7 rb), sedangkan Sarana Menara Nusantara Tbk. diperdagangkan di Rp388 (kapitalisasi pasar 23,17 T, volume 24 jam 43,43 jt). Perbedaan utamanya: Sarana Menara Nusantara Tbk. jauh lebih besar — sekitar 73,3× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Sarana Menara Nusantara Tbk. lebih aktif diperdagangkan (43,43 jt vs 41,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | TOWR | |
|---|---|---|
Kapitalisasi Pasar | 316,25 M | 23,17 T |
Volume | 41,7 rb | 43,43 jt |
Lot | 417 | 434,3 rb |
Perputaran | 9,66 jt | 16,85 M |
Harga Rata-rata | 231,65 | 387,95 |
Nilai Transaksi | 9,66 jt | 16,85 M |
Harga Ekuilibrium Indikatif | 230 | 388 |
Volume Ekuilibrium Indikatif | 2,4 rb | 3,03 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Sarana Menara Nusantara Tbk (the company) was established based on Deed of Establishment (Article of Association) No.31 dated June 2, 2008 drawn up in the presence of Dr. Irawan Soerodjo, S.H., MSi., Notary in Jakarta.The Company's articles of association has been amended several times, most recently by notarial deed No. 71 of Irawan Soerodjo, S.H., dated Nov 18, 2009, concerning among others, the change in par value, and public offering
Selengkapnya di halaman TOWR →